Business Description
Pixium Vision SA
ISIN : FR001400JX97
Share Class Description:
STU:PXH1: Ordinary SharesCompare
Compare
Traded in other countries / regions
PXH1.GermanyALPIX.France0QVB.UKPXMVD.USA IPO Date
2018-05-14Description
Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.69 | |||||
| Equity-to-Asset | -0.23 | |||||
| Debt-to-Equity | -3.89 | |||||
| Debt-to-EBITDA | -1.19 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.56 | |||||
| Beneish M-Score | 354.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.1 | |||||
| 3-Year EBITDA Growth Rate | 21.6 | |||||
| 3-Year EPS without NRI Growth Rate | 19 | |||||
| 3-Year FCF Growth Rate | 14.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.57 | |||||
| 9-Day RSI | 43.57 | |||||
| 14-Day RSI | 47.81 | |||||
| 6-1 Month Momentum % | -76.68 | |||||
| 12-1 Month Momentum % | -87.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 1.19 | |||||
| Cash Ratio | 0.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.8 | |||||
| Shareholder Yield % | -242.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 7942.76 | |||||
| Net Margin % | 7253.79 | |||||
| FCF Margin % | 5708.28 | |||||
| ROE % | -929.15 | |||||
| ROA % | -69.78 | |||||
| ROIC % | -181.34 | |||||
| ROC (Joel Greenblatt) % | -811.96 | |||||
| ROCE % | -115.79 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.45 | |||||
| EV-to-Forward-EBIT | -0.31 | |||||
| EV-to-EBITDA | -0.45 | |||||
| EV-to-Forward-EBITDA | -0.35 | |||||
| EV-to-Revenue | -28.7 | |||||
| EV-to-Forward-Revenue | 6.01 | |||||
| EV-to-FCF | -0.5 | |||||
| Earnings Yield (Greenblatt) % | -222.22 | |||||
| FCF Yield % | -1074.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pixium Vision SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | -0.145 | ||
| EPS (TTM) (€) | -8 | ||
| Beta | 0 | ||
| Volatility % | 197.77 | ||
| 14-Day RSI | 47.81 | ||
| 14-Day ATR (€) | 0.014473 | ||
| 20-Day SMA (€) | 0.3195 | ||
| 12-1 Month Momentum % | -87.66 | ||
| 52-Week Range (€) | 0.0505 - 6.8 | ||
| Shares Outstanding (Mil) | 3.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pixium Vision SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pixium Vision SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pixium Vision SA Frequently Asked Questions
What is Pixium Vision SA(STU:PXH1)'s stock price today?
The current price of STU:PXH1 is €0.32. The 52 week high of STU:PXH1 is €6.80 and 52 week low is €0.05.
When is next earnings date of Pixium Vision SA(STU:PXH1)?
The next earnings date of Pixium Vision SA(STU:PXH1) is .
Does Pixium Vision SA(STU:PXH1) pay dividends? If so, how much?
Pixium Vision SA(STU:PXH1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers